MDxHealth SA
Provides molecular diagnostic tests to personalize urologic condition treatment.
MDXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974461940
- LEI:
- 549300J3MG9F9B5FY646
- Country:
- Belgium
- Address:
- Rue d'Abhooz 31, 4040 Herstal
- Website:
- https://mdxhealth.com/
- Industry:
- Other human health activities
Description
MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-25 22:00 |
PR 2023 04 25.pdf
|
English | PDF • 126.9 KB | ||
| 2023-04-25 22:00 |
PR 2023 04 25 FR.pdf
|
French | PDF • 207.4 KB | ||
| 2023-04-19 22:00 |
PR 2023 04 19 EN.pdf
|
English | PDF • 232.7 KB | ||
| 2023-04-19 22:00 |
PR 2023 04 19 FR.pdf
|
French | PDF • 184.9 KB | ||
| 2023-04-07 22:30 |
PR 2023 04 07 FR.pdf
|
English | PDF • 208.6 KB | ||
| 2023-04-07 22:30 |
PR 2023 04 07 EN.pdf
|
French | PDF • 191.4 KB | ||
| 2023-03-13 08:00 |
PR 2023 03 13 EN.pdf
|
English | PDF • 221.7 KB | ||
| 2023-03-08 23:00 |
mdxhealth-project-meuse-overallotment-new-denominator-press_English.pdf
|
English | PDF • 146.1 KB | ||
| 2023-03-08 23:00 |
mdxhealth-project-meuse-overallotment-new-denominator-press_French.pdf
|
French | PDF • 170.4 KB | ||
| 2023-03-08 22:00 |
PR 2023 03 08_English.pdf
|
English | PDF • 311.2 KB | ||
| 2023-03-08 22:00 |
PR 2023 03 08_french.pdf
|
French | PDF • 359.8 KB | ||
| 2023-03-06 23:30 |
PR 2023 03 06 EN.pdf
|
English | PDF • 230.0 KB | ||
| 2023-03-06 23:30 |
PR 2023 03 06 FR.pdf
|
French | PDF • 224.2 KB | ||
| 2023-03-03 22:30 |
MDxHealth Shareholder Transparency 3.3.2023_English.pdf
|
English | PDF • 194.2 KB | ||
| 2023-03-03 22:30 |
MDxHealth Shareholder Transparency 3.3.2023_French.pdf
|
French | PDF • 205.3 KB |
Automate Your Workflow. Get a real-time feed of all MDxHealth SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MDxHealth SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MDxHealth SA via our API.
Peer Companies
